Try our corporate solution for free!
+1 (212) 419-5770

Global in vitro diagnostics revenues by top companies 2017 and 2024

As of 2017, Swiss-based pharmaceutical company Roche was the global leader in the in vitro diagnostics (IVD) market, generating over 10 billion U.S. dollars in revenues in this segment. According to projections, Roche will maintain the leading position until 2024, exceeding 14 billion dollars. Roche’s major competitors are Abbott Laboratories and Danaher from the United States. Among the top 10 companies, U.S. company Exact Sciences from Wisconsin is expected to have the most impressive growth, increasing its IVD revenues nearly sevenfold between 2017 and 2024.

What are in vitro diagnostics?

In vitro diagnostics allow for medical professionals to get information about diseases, conditions, and infections. These tests can be conducted within a laboratory and sometimes within a patient's home. IVDs are a large subgroup of medical devices which can range in size from small handheld devices to large complex laboratory instruments. In general, samples derived from the human body are examined ‘in vitro’ – meaning “in the glass” – for purposes of screening, diagnosis, or monitoring. Today, most medical treatments are based on IVD outcomes. IVDs are also essential for the increasing personalization of medical treatments.

Roche Diagnostics

The Roche Group from Switzerland is one of the top global pharmaceutical companies. Nevertheless, the company has also a strong medical device division - Roche Diagnostics – which is mainly represented by in vitro diagnostics. Among the best-known and best-selling diagnostic devices by Roche are devices from the cobas series, used in immunodiagnostics, clinical chemistry, and virology.

Global top 10 companies based on in vitro diagnostics revenue in 2017 and 2024

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% Discount until October 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

September 2018



Survey time period

as of September 2018

Supplementary notes

Excludes glucose test systems which are included in diabetic care classification.
* Projected.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "In Vitro Diagnostics"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.